IDiyas

For the Inventor, By the Inventor

Berwyn, PA, United States of America

Stewart Campbell Pearson

USPTO Granted Patents = 17

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:

goldMedal17 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal2 out of 33 
 
Affinium Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1998-2006

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6995254 - [object Object] (2006-02-07),
2. 6753172 - FabI (2004-06-22),
3. 6682919 - FabH (2004-01-27),
4. 6432670 - Polynucleotides encoding staphylcoccal FAB I enoyl-ACP reductase (2002-08-13),
5. 6372487 - Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein (2002-04-16),
6. 6346395 - Nucleic acids encoding Streptococcus pneumoniae FabG (2002-02-12),
7. 6258934 - FabD (2001-07-10),
8. 6165472 - folC from Streptococcus pneumoniae (2000-12-26),
9. 6060055 - Div1b (2000-05-09),
10. 6022706 - Div1b (2000-02-08),
11. 5955304 - DivIB (1999-09-21),
12. 5919664 - Peptide release factor, prfC (RF-3), a GTP-Binding protein (1999-07-06),
13. 5885572 - FabH (1999-03-23),
14. 5882898 - Streptococcus pneumoniae polynucleotides which encode (1999-03-16),
15. 5827689 - FabD polynucleotides (1998-10-27),

Title: Stewart Campbell Pearson: Innovator in Prokayrotic Polypeptides

Introduction

Stewart Campbell Pearson is a notable inventor based in Berwyn, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and their applications in treating infections. With a total of 17 patents to his name, Pearson's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents, Pearson has disclosed innovative methods related to Prokayrotic FAB I polypeptides and the DNA (RNA) encoding such FAB I. His patents detail procedures for producing these polypeptides through recombinant techniques. Furthermore, he has outlined methods for utilizing FAB I in the treatment of infections, including bacterial infections. His work also includes the development of antagonists against FAB I, which can serve as therapeutics for treating infections such as staphylococcal infections. Additionally, Pearson has created diagnostic assays for detecting diseases associated with the presence of FAB I nucleic acid sequences and polypeptides in hosts.

Career Highlights

Throughout his career, Stewart Campbell Pearson has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Affinium Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Pearson has collaborated with notable individuals in his field, including David John Payne and John Timothy Lonsdale. These collaborations have likely enriched his research and development efforts.

Conclusion

Stewart Campbell Pearson is a distinguished inventor whose work in Prokayrotic polypeptides has advanced the treatment of bacterial infections and diagnostics. His contributions continue to influence the field of biotechnology and medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…